vs
ALAMO GROUP INC（ALG）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是ALAMO GROUP INC的1.7倍（$622.0M vs $373.6M），Royalty Pharma plc净利率更高（34.4% vs 4.2%，领先30.3%），Royalty Pharma plc同比增速更快（4.8% vs -3.0%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -6.3%）
Alamo Drafthouse Cinema是1997年在美国得克萨斯州奥斯汀成立的连锁影院品牌，主打观影期间提供餐食与饮品服务，同时严格要求观众遵守观影礼仪，2024年6月该连锁品牌被索尼影视体验部门收购。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
ALG vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.7倍
$373.6M
营收增速更快
RPRX
高出7.8%
-3.0%
净利率更高
RPRX
高出30.3%
4.2%
两年增速更快
RPRX
近两年复合增速
-6.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $373.6M | $622.0M |
| 净利润 | $15.5M | $214.2M |
| 毛利率 | 22.7% | — |
| 营业利润率 | 6.0% | 62.4% |
| 净利率 | 4.2% | 34.4% |
| 营收同比 | -3.0% | 4.8% |
| 净利润同比 | -44.8% | 2.9% |
| 每股收益（稀释后） | $1.28 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALGRPRX
| Q4 25 | $373.6M | $622.0M | ||
| Q3 25 | $420.0M | $609.3M | ||
| Q2 25 | $419.1M | $578.7M | ||
| Q1 25 | $390.9M | $568.2M | ||
| Q4 24 | $385.3M | $593.6M | ||
| Q3 24 | $401.3M | $564.7M | ||
| Q2 24 | $416.3M | $537.3M | ||
| Q1 24 | $425.6M | $568.0M |
净利润ALGRPRX
| Q4 25 | $15.5M | $214.2M | ||
| Q3 25 | $25.4M | $288.2M | ||
| Q2 25 | $31.1M | $30.2M | ||
| Q1 25 | $31.8M | $238.3M | ||
| Q4 24 | $28.1M | $208.2M | ||
| Q3 24 | $27.4M | $544.0M | ||
| Q2 24 | $28.3M | $102.0M | ||
| Q1 24 | $32.1M | $4.8M |
毛利率ALGRPRX
| Q4 25 | 22.7% | — | ||
| Q3 25 | 24.2% | — | ||
| Q2 25 | 25.8% | — | ||
| Q1 25 | 26.3% | — | ||
| Q4 24 | 23.8% | — | ||
| Q3 24 | 25.1% | — | ||
| Q2 24 | 26.0% | — | ||
| Q1 24 | 26.2% | — |
营业利润率ALGRPRX
| Q4 25 | 6.0% | 62.4% | ||
| Q3 25 | 8.9% | 70.1% | ||
| Q2 25 | 11.2% | 36.3% | ||
| Q1 25 | 11.4% | 94.0% | ||
| Q4 24 | 8.9% | 60.9% | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 10.4% | 50.2% | ||
| Q1 24 | 11.0% | -13.0% |
净利率ALGRPRX
| Q4 25 | 4.2% | 34.4% | ||
| Q3 25 | 6.0% | 47.3% | ||
| Q2 25 | 7.4% | 5.2% | ||
| Q1 25 | 8.1% | 41.9% | ||
| Q4 24 | 7.3% | 35.1% | ||
| Q3 24 | 6.8% | 96.3% | ||
| Q2 24 | 6.8% | 19.0% | ||
| Q1 24 | 7.5% | 0.8% |
每股收益（稀释后）ALGRPRX
| Q4 25 | $1.28 | $0.49 | ||
| Q3 25 | $2.10 | $0.67 | ||
| Q2 25 | $2.57 | $0.07 | ||
| Q1 25 | $2.64 | $0.55 | ||
| Q4 24 | $2.33 | $0.46 | ||
| Q3 24 | $2.28 | $1.21 | ||
| Q2 24 | $2.35 | $0.23 | ||
| Q1 24 | $2.67 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $309.7M | $618.7M |
| 总债务越低越好 | $190.7M | $9.0B |
| 股东权益账面价值 | $1.1B | $9.7B |
| 总资产 | $1.6B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资ALGRPRX
| Q4 25 | $309.7M | $618.7M | ||
| Q3 25 | $244.8M | $938.9M | ||
| Q2 25 | $201.8M | $631.9M | ||
| Q1 25 | $200.3M | $1.1B | ||
| Q4 24 | $197.3M | $929.0M | ||
| Q3 24 | $140.0M | $950.1M | ||
| Q2 24 | $118.5M | $1.8B | ||
| Q1 24 | $121.8M | $843.0M |
总债务ALGRPRX
| Q4 25 | $190.7M | $9.0B | ||
| Q3 25 | $194.4M | $8.9B | ||
| Q2 25 | $198.1M | $8.0B | ||
| Q1 25 | $201.8M | $7.6B | ||
| Q4 24 | $205.5M | $7.6B | ||
| Q3 24 | $209.2M | $7.6B | ||
| Q2 24 | $278.6M | $7.6B | ||
| Q1 24 | $306.5M | $6.1B |
股东权益ALGRPRX
| Q4 25 | $1.1B | $9.7B | ||
| Q3 25 | $1.1B | $9.6B | ||
| Q2 25 | $1.1B | $9.5B | ||
| Q1 25 | $1.1B | $9.8B | ||
| Q4 24 | $1.0B | $10.3B | ||
| Q3 24 | $1.0B | $10.3B | ||
| Q2 24 | $979.7M | $9.8B | ||
| Q1 24 | $956.6M | $9.9B |
总资产ALGRPRX
| Q4 25 | $1.6B | $19.6B | ||
| Q3 25 | $1.6B | $19.3B | ||
| Q2 25 | $1.6B | $18.3B | ||
| Q1 25 | $1.5B | $17.6B | ||
| Q4 24 | $1.5B | $18.2B | ||
| Q3 24 | $1.5B | $18.0B | ||
| Q2 24 | $1.5B | $17.7B | ||
| Q1 24 | $1.5B | $16.1B |
负债/权益比ALGRPRX
| Q4 25 | 0.17× | 0.92× | ||
| Q3 25 | 0.17× | 0.93× | ||
| Q2 25 | 0.18× | 0.84× | ||
| Q1 25 | 0.19× | 0.78× | ||
| Q4 24 | 0.20× | 0.74× | ||
| Q3 24 | 0.21× | 0.74× | ||
| Q2 24 | 0.28× | 0.78× | ||
| Q1 24 | 0.32× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $75.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $69.9M | — |
| 自由现金流率自由现金流/营收 | 18.7% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | 4.84× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $146.9M | — |
8季度趋势，按日历期对齐
经营现金流ALGRPRX
| Q4 25 | $75.1M | $827.1M | ||
| Q3 25 | $65.5M | $702.6M | ||
| Q2 25 | $22.7M | $364.0M | ||
| Q1 25 | $14.2M | $596.1M | ||
| Q4 24 | $79.1M | $742.5M | ||
| Q3 24 | $96.3M | $703.6M | ||
| Q2 24 | $33.2M | $658.2M | ||
| Q1 24 | $1.1M | $664.6M |
自由现金流ALGRPRX
| Q4 25 | $69.9M | — | ||
| Q3 25 | $53.1M | — | ||
| Q2 25 | $15.7M | — | ||
| Q1 25 | $8.2M | — | ||
| Q4 24 | $73.1M | — | ||
| Q3 24 | $88.4M | — | ||
| Q2 24 | $28.8M | — | ||
| Q1 24 | $-5.5M | — |
自由现金流率ALGRPRX
| Q4 25 | 18.7% | — | ||
| Q3 25 | 12.6% | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 19.0% | — | ||
| Q3 24 | 22.0% | — | ||
| Q2 24 | 6.9% | — | ||
| Q1 24 | -1.3% | — |
资本支出强度ALGRPRX
| Q4 25 | 1.4% | — | ||
| Q3 25 | 3.0% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 1.6% | — |
现金转化率ALGRPRX
| Q4 25 | 4.84× | 3.86× | ||
| Q3 25 | 2.58× | 2.44× | ||
| Q2 25 | 0.73× | 12.06× | ||
| Q1 25 | 0.45× | 2.50× | ||
| Q4 24 | 2.82× | 3.57× | ||
| Q3 24 | 3.51× | 1.29× | ||
| Q2 24 | 1.17× | 6.45× | ||
| Q1 24 | 0.03× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALG
| Wholegood Units | $293.2M | 78% |
| Parts | $61.6M | 16% |
| Other Revenue | $18.9M | 5% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
